...
首页> 外文期刊>Angewandte Chemie >Covalent Modification of a Cysteine Residue in the XPB Subunit of the General Transcription Factor TFIIH Through Single Epoxide Cleavage of the Transcription Inhibitor Triptolide
【24h】

Covalent Modification of a Cysteine Residue in the XPB Subunit of the General Transcription Factor TFIIH Through Single Epoxide Cleavage of the Transcription Inhibitor Triptolide

机译:一般转录因子TFIIH XPB亚基中的半胱氨酸残基的共价修饰通过转录抑制剂雷公藤内酯的单环氧化物切割。

获取原文
获取原文并翻译 | 示例
           

摘要

Triptolide is a key component of the traditional Chinese medicinal plant Thunder God Vine and has potent anticancer and immunosuppressive activities. It is an irreversible inhibitor of eukaryotic transcription through covalent modification of XPB, a subunit of the general transcription factor TFIIH. Cys342 of XPB was identified as the residue that undergoes covalent modification by the 12,13-epoxide group of triptolide. Mutation of Cys342 of XPB to threonine conferred resistance to triptolide on the mutant protein. Replacement of the endogenous wild-type XPB with the Cys342Thr mutant in a HEK293T cell line rendered it completely resistant to triptolide, thus validating XPB as the physiologically relevant target of triptolide. Together, these results deepen our understanding of the interaction between triptolide and XPB and have implications for the future development of new analogues of triptolide as leads for anticancer and immunosuppressive drugs.
机译:雷公藤甲素是传统中草药雷神藤的关键成分,具有有效的抗癌和免疫抑制作用。通过共价修饰XPB(一种通用转录因子TFIIH的亚基),它是一种不可逆的真核转录抑制剂。 XPB的Cys342被鉴定为经过雷公藤内酯醇的12,13-环氧基共价修饰的残基。 XPB的Cys342突变为苏氨酸使突变蛋白对雷公藤甲素具有抗性。在HEK293T细胞系中用Cys342Thr突变体替代内源性野生型XPB,使其完全耐受雷公藤甲素,从而证实XPB是雷公藤内酯的生理相关靶标。总之,这些结果加深了我们对雷公藤甲素与XPB之间相互作用的理解,并对雷公藤内酯作为抗癌和免疫抑制药物的新类似物的未来发展产生了影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号